The ReDOS Study and How Using Dose Escalation of Stivarga (regorafenib) Is a Good Approach For A Hard To Tolerate Drug - 101341

Spotlight
Video

The ReDOS Study and How Using Dose Escalation of Stivarga (regorafenib) Is a Good Approach For A Hard To Tolerate Drug

obr has 439 videos Subscribe Here

Loading........
Description: Stivarga (regorafenib) is an effective drug but not one that is easily tolerable. Howard Hochster, MD, talks to us about the ReDOS study and its outcomes at the 2018 Gastrointestinal Cancers Symposium.
Shared By : obr
Posted on : 01/30/18
Added : 11 months ago